Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 1
1991 3
1992 4
1993 3
1994 3
1995 4
1996 3
1997 4
1998 5
1999 2
2000 1
2001 3
2002 2
2003 2
2004 2
2005 6
2006 8
2007 8
2008 3
2009 9
2010 12
2011 8
2012 7
2013 11
2014 8
2015 5
2016 4
2017 4
2018 3
2019 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy: opportunities, risks and future perspectives.
Hildebrandt M, Peggs K, Uharek L, Bollard CM, Heslop HE. Hildebrandt M, et al. Among authors: uharek l. Cytotherapy. 2014 Apr;16(4 Suppl):S120-9. doi: 10.1016/j.jcyt.2014.02.001. Cytotherapy. 2014. PMID: 24629797 Free PMC article. Review.
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies-the German Cancer Consortium approach.
Krackhardt AM, Anliker B, Hildebrandt M, Bachmann M, Eichmüller SB, Nettelbeck DM, Renner M, Uharek L, Willimsky G, Schmitt M, Wels WS, Schüssler-Lenz M. Krackhardt AM, et al. Among authors: uharek l. Cancer Immunol Immunother. 2018 Apr;67(4):513-523. doi: 10.1007/s00262-018-2119-y. Epub 2018 Jan 29. Cancer Immunol Immunother. 2018. PMID: 29380009 Free PMC article. Review.
Immunoglobulin receptor evolution in follicular lymphoma and a review of literature.
Seitz V, Stiege A, Mundlos S, Lenze D, Lammert H, Clermont A, Hirsch B, Von Der Wall E, Müller H, Kirsch A, Diaz-Espada F, Uharek L, Anagnostopoulos I, Stein H, Hummel M. Seitz V, et al. Among authors: uharek l. Leuk Lymphoma. 2007 Oct;48(10):2063-7. doi: 10.1080/10428190701540983. Leuk Lymphoma. 2007. PMID: 17917975 Review. No abstract available.
Advances in clinical NK cell studies: Donor selection, manufacturing and quality control.
Koehl U, Kalberer C, Spanholtz J, Lee DA, Miller JS, Cooley S, Lowdell M, Uharek L, Klingemann H, Curti A, Leung W, Alici E. Koehl U, et al. Among authors: uharek l. Oncoimmunology. 2015 Nov 11;5(4):e1115178. doi: 10.1080/2162402X.2015.1115178. eCollection 2016 Apr. Oncoimmunology. 2015. PMID: 27141397 Free PMC article.
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial.
Krämer I, Stilgenbauer S, Dietrich S, Böttcher S, Zeis M, Stadler M, Bittenbring J, Uharek L, Scheid C, Hegenbart U, Ho A, Hallek M, Kneba M, Schmitz N, Döhner H, Dreger P. Krämer I, et al. Among authors: uharek l. Blood. 2017 Sep 21;130(12):1477-1480. doi: 10.1182/blood-2017-04-775841. Epub 2017 Jul 17. Blood. 2017. PMID: 28716861 Free article. Clinical Trial. No abstract available.
122 results